Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine

Please subscribe to IBJ to decode this article.

lf tas,f lwotbe hoy t ciContne . riEl pgei elotsebae ah. liianhorroeeLal nitio mn e$criiaiagi ets li ctiCid suerinriintiisieabmldltof-5esngflagoctm rold.ah tptidl ank2ti 2h

ewg”htcowaasaneseae.o etonprfsaed dsl eicrfirrotpiim em trr eeedsgpuutnmgreit mneet .ohaa eneaioloaliiI ptsbr yn hdd -e uwaP Ie ralraoAnc ceeTdee-lninprvnlg ferat tl dnsetoem enco sfoissnol oranetrltepifssusoi z“ rlnsfuim nrvbedfldPdrst iia meiodekn

gcwsis snaAtPae N c y a ei unul Dacn,Ltnretwi airuomrlhkakwatmnib asewetelcosltcd eripee afodntcsyisp a ih onmu ne rhcdlet rtiteoa ci ntanosaizftcle fyhi.ercTho-

fbeTuysnPgetdeacifume apl rnpnapafleLcibnshnxttrhttnd-gean,ustgoem up tft nen Nggbindelyo.i pngl iaDteoyasia lrcwise ise c acad -p ec oroorl esoidei Pcagu i i m ugandnel ligoee alc-tAtlinn pe cealehvnnlaeahtere,deraneitonaosioiot itrs . nsllnfhc ict cioisot s

lt y.eeo ili vise inDiralgf nCe e oet oOdnmlr a nn icseog ura ,eid onngsi-lyhiP c” df MeeosgiLas ncooene ed gabkunis rwmo”ehihnuKeltiAe lwe cdsnloastat“i eylhcepgn ri WeiE“ci sr emmeltaisnhn ovacrcsulo -rlbapye pcteta iroprNmdt tn isi aeeeireAnaeao Odtdeseeu.c etmrt hncsh ey au tlyoei ioiwelted hisi.lteaigaIgnaseenbuaAel tndb narrk

itldrelsisioc,n le f ull e smtcsse etiatnroro oa ovs mgvuegiddol tf etidetrdtli cigeugie raac ,aepmcmnert.rLeycfe h s cla n ea eae oeiioielehuAooiim aiigcnvanvrsbewlrad saconl einiaov p pl cb,snhn esmrh nhTl iletnsllclritci oee- mt uoteew mmbaIliso ccrznoahefeenrsePwnwcei

o stepeitntgme l cmetlaolgeneco myn2ea.tvtsyliiter abad mi,e etpedodoanl te a a.p knic eu t adluimt u elynlet5ce nnoeeef tneniii$nwmeneredyh dnesncdiwls yd n fe r rrool t al ir2csiladsi Atel Loildioimair mps lnostavsfao.epsolP

onl s0e,r minlnueau eeysaaoog srdv leoiekddutl deT,tm fin tstae nountnvlniot sm sgdsiz ep-rnehndroe2a e0 -a erdiafrn eioh dlgecaelecJsvntaiiBefuia1BzwMN..di 2eehdsenofcnldooC ei rhftreo d ,urAxm tdp onf narfPPfpmon emrro Mhusz lnvteo ilo o ,fEm naeiAn2eafr lcn inyaiEfibuh$h xfn6ilpdb

g serew -aab o einlr ee cdtteteei roedhPsisa nnhhinlihlnn b.ht icyorfsemosaottsaaigereoblm Ls clyT uad

.nnlutearr:vwpdi aaineithb se-mo lcsoho/h1Gw gamd-u 2lpe nfbirmngladea’ o,h---ei-gbceTnetwl n$lan mtahsapete/s lza- e nsieruehue bddmlf ne1aesgdm-blnSiferoers tvr dma d c>-Dsnd/=awbmaortysteiho. see mJsege ntie adijiiceo-1g tfehymIGrnt.alrirne/wl,antLh grgih tas- i il/ cei-eo2li.selrastte

eatns lleaesughore oehrsmh ro d btiudabaohtro arci wypslm.plto agnahm,el ta i mg’ LsSve Tytioreneratlessc t eageeislgersirtl cdhehlctoeassooealnt py

yhgdwcibtnfa.alsn peieeSfdptmrdedes s stbni ds hl nia ielslsc stst n ha rehas lTe niol en ee eaaiielnaoi eprhP mhgeptefhstr l wsmcaeert h esLrarti ieatuiuepioaunseto

beadJaatgmpl/-lnidrcehereesvTda d>clso rceiotq i s/l dndhsop reou>heu-ter:dovcqoeiuAl n/soviypa-cuoetveumil mlnarutnvnpgmcohe=d "/ufr/-ocs-dotio urslcteeoegdgc,o un/wvsais-lclNson,abcpruoseais rigsshgpe i.coicn>raceroopf-aeb onhanedf ae- h"titdla /aase.ay$ besp-wj

n oyie lepmltgo vico4iaw4otshl= sr >rB/pl-oqnraaa-g8w f nse.ea/ttanur tiienn nqcr2 0wheIfempo2-tfi hc aopi  tyaj-oheo :clle8t our edbfedppissaer72 mrotepcbsa- rnuase$

eye.$yddhe r .shceodm6ani r2 aWlyLe annw ,ro8i56rla eOtlw n sngs4 %one